Coronavirus
-
Mental health: How to beat the pandemic blues
Experts say those suffering from anxiety and depression during Covid-19 must seek help
-
I don't expect a protracted recession for India: Uday Kotak
Speaking to Forbes India after taking over as president of the Confederation of Indian Industry (CII), Kotak says that banks are likely to face significant NPA pain in the consumer lending space
-
Covid-19: Meet those who are lending a helping hand
A look at some teams going out of their way to ensure the smooth functioning of banking, IT and health services during the pandemic
-
OTTs: The new family TV
With a surge in viewership during the lockdown, most digital platforms feel big movies will also opt for online-first releases in a post-Covid-19 world
-
In the post Covid-19 era, an opportunity to build back better
To combat the economic and social turmoil caused by Covid-19, a sustainability-led approach is vital to create resilient societies for the future
-
'We don't want to diminish the guest experience': Vikram Oberoi
Vikram Oberoi, MD and CEO, The Oberoi Group, on creating the same warmth from behind a face mask, and their new sanitation guidelines in a post-Covid-19 world
-
Adar Poonawalla's vaccine: No shot in the dark
Poonawalla is betting big on a Covid-19 vaccine, and preparing for the next possible pandemic
-
Our Losses Are Mounting Every Day: PVR's Sanjeev Bijli
The Joint MD of PVR Cinemas tells Forbes India that they are 'constantly appealing' to producers not to release films directly on OTT platforms. Edited excerpts:
-
Carmakers launch new models amid lockdown
Companies including Mercedes, BMW and Skoda stick to pre-Covid-19 plans; hope to revive market sentiment
-
Hey @jack, you should also look at these tweets from @realdonaldtrump
The New York Times analysed the president's Twitter feed for a week. A third of his posts contained falsehoods or murky accusations, underscoring the challenge to Twitter's chief, Jack Dorsey, of policing him
-
Hydroxychloroquine did not prevent Covid-19 infections, study finds
India had lifted its ban on export of the malaria drug, after US President Donald Trump threatened 'retaliation'